Gene Delivery Technologies Market

Gene Delivery Technologies Market Forecasts to 2028 – Global Analysis By Method (Ex-Vivo, In-Vivo, In Vitro), Application (Gene Therapy, Cell Therapy, Vaccines, Research), Mode (Biological, Chemical, Physical) and By Geography

4.2 (53 reviews)
Published: May 2021 ID: SMRC20527
4.2 (53 reviews)
Published: May 2021 ID: SMRC20527

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Gene Delivery Technologies Market is accounted for $2.60 billion in 2020 and is expected to reach $9.19 billion by 2028 growing at a CAGR of 17.1% during the forecast period. Advantages like briefness and nontoxicity nature, technological advancements in viral vectors, growing pipeline of advanced therapies, are the factors driving the market growth. However, several clinical challenges associated with viral systems have spurred the usage of chemical methods which may restrain the growth of the market.

Gene delivery is the process of introducing foreign gene delivery, such as DNA or RNA, into host cells, the technologies used to implement the gene delivery are gene delivery technologies. Gene delivery technology is widely applied for various diseases treatment caused from bacterial infections, exterior chemical toxins, viral invasions, malignant tumours and endogenous genetic defects. The advent of cell and gene therapies played a major role in reshaping the entire pharmaceutical ecosystem by transforming the treatment of genetic and intractable diseases.

Based on the application, the gene therapy segment is going to have lucrative growth during the forecast period due to the growing acceptance of gene-based therapies and the consequent increase in the number of clinical research initiatives have fuelled the revenue generation in this segment. Increasing acceptance of gene therapy products worldwide has also accelerated the segment growth.

By geography, North America is going to have high growth during the forecast period due to the substantial number of clinical trials are underway to assess the efficacy and safety of gene therapies as a viable treatment for incurable diseases such as cancer, genetic disorders, HIV in the U.S., Many innovative projects covering viral vector-based gene therapy trials for rare conditions are being introduced in North America. These factors increase the demand of the North America region in the market for gene delivery technologies.

Some of the key players profiled in the Gene Delivery Technologies Market include Bio-Rad Laboratories, Inc., Catalent Inc., OriGene Technologies, Inc., Oxford Biomedica,  Promega Corporation, QIAGEN, SignaGen Laboratories, Sirion-Biotech GmbH, System Biosciences llc, Takara Bio Inc., Thermo Fisher Scientific, Inc., Vectalys and Horizon Discovery Group Plc.

Methods Covered:
• Ex-Vivo
• In-Vivo
• In Vitro

Applications Covered:
• Gene Therapy
• Cell Therapy
• Vaccines
• Research   

Modes Covered:
• Biological
• Chemical
• Physical  

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.